TABATON, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 19.498
AS - Asia 1.793
NA - Nord America 1.570
SA - Sud America 195
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 37
OC - Oceania 2
Totale 23.175
Nazione #
IT - Italia 19.171
US - Stati Uniti d'America 1.456
SG - Singapore 769
CN - Cina 468
VN - Vietnam 281
FR - Francia 160
BR - Brasile 117
BD - Bangladesh 90
HK - Hong Kong 71
CA - Canada 39
DE - Germania 39
FI - Finlandia 32
AR - Argentina 31
JP - Giappone 21
CH - Svizzera 17
MX - Messico 17
CO - Colombia 14
IN - India 14
IQ - Iraq 13
GB - Regno Unito 12
JM - Giamaica 12
EC - Ecuador 11
NL - Olanda 11
CR - Costa Rica 10
ID - Indonesia 9
ZA - Sudafrica 8
CL - Cile 7
HN - Honduras 7
IE - Irlanda 7
RU - Federazione Russa 7
SV - El Salvador 7
UA - Ucraina 7
VE - Venezuela 7
GT - Guatemala 6
PH - Filippine 6
PK - Pakistan 6
SA - Arabia Saudita 6
SC - Seychelles 6
EG - Egitto 5
PY - Paraguay 5
TH - Thailandia 5
ES - Italia 4
HR - Croazia 4
MY - Malesia 4
PL - Polonia 4
AL - Albania 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BE - Belgio 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KE - Kenya 3
NI - Nicaragua 3
TN - Tunisia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MM - Myanmar 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
SE - Svezia 2
SN - Senegal 2
TR - Turchia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BM - Bermuda 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
ZM - Zambia 1
Totale 23.095
Città #
Genova 12.792
Genoa 3.730
Rapallo 1.513
Vado Ligure 996
San Jose 435
Singapore 336
Lauterbourg 155
Ashburn 146
Ho Chi Minh City 92
Hanoi 71
New York 68
Hong Kong 64
Beijing 57
Santa Clara 55
Bordighera 54
Frankfurt am Main 35
Helsinki 32
Los Angeles 27
Phoenix 22
Chicago 21
Tokyo 20
Zurich 17
Council Bluffs 15
Dallas 15
Tianjin 15
Da Nang 13
Haiphong 13
Houston 12
Milan 11
Rome 11
Amsterdam 9
Biên Hòa 9
Buffalo 9
Charlotte 9
Kingston 9
Guangzhou 8
Orem 8
São Paulo 8
Mexico City 7
Miami 7
San José 7
San Salvador 7
Toronto 7
Detroit 6
Dublin 6
Newark 6
Philadelphia 6
Thái Bình 6
Atlanta 5
Bologna 5
Brasília 5
Catania 5
Chennai 5
Guatemala City 5
Montreal 5
San Francisco 5
Seattle 5
Washington 5
Alpharetta 4
Belo Horizonte 4
Cape Town 4
Caracas 4
Cardiff 4
Des Moines 4
Fredericksburg 4
Guayaquil 4
Jersey City 4
Mobile 4
Naples 4
Quito 4
Riverside 4
Warsaw 4
Amman 3
Baku 3
Bogotá 3
Boston 3
Brooklyn 3
Cali 3
Concepción 3
Corona 3
Denver 3
Goiânia 3
Greenville 3
Ha Long 3
Highland 3
Hải Dương 3
Juiz de Fora 3
Kansas City 3
Kuala Lumpur 3
Lafayette 3
Lancaster 3
Las Vegas 3
Madrid 3
Managua 3
Nairobi 3
Ninh Bình 3
Pine Bluff 3
Porto Alegre 3
Quảng Ngãi 3
San Pedro Sula 3
Totale 21.167
Nome #
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 260
Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation 231
A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. 207
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. 205
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 200
Lipoperoxidation is selectively involved in progressive supranuclear palsy 198
Survival rate in Patients affected by Dementia followed by memory clinics (UVA) in Italy 192
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 191
Early glycoxidation damage in brains from Down’s syndrome 190
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy 189
Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway. 188
Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment. 188
Direct immunofluorescence in sural nerve biopsies. 185
Balance features in Alzheimer's disease and amnestic mild cognitive impairment 184
JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. 184
RNA polymerase III drives alternative splicing of the Potassium Channel Interacting Protein contributing to brain complexity and neurodegeneration 184
Alternative, non-secretase processing of Alzheimer’s b-amyloid precursor protein during apoptosis by Caspase-6 and-8 182
GFAP expression of human Schwann cells in tissue culture. 179
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 178
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 178
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 177
Fibroblasts from FAD-linked presenilin 1 mutations display a normal unfolded protein response but overproduce Abeta42 in response to tunicamycin 176
Oxidative stress induces increase in intracellular amyloid-protein production and selective activation of I and II PKCs in NT2 cells 176
Mutant presenilin 1 increases the expression and activity of BACE1. 175
Elevation of βAmyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment. 175
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein 175
Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation 174
The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease 172
Schwann cell GFAP expression increases in axonal neuropathies. 167
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 166
Oxidative stress increase expression and activity of BACE in NT2 neurons 164
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment 163
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules 163
Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment. 162
Motor and sensory evoked potentials in progressive supranuclear palsy. 161
A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1 160
Beta-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. 159
HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. 158
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy. 157
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 157
Amyloid-b deposition in Alzheimer transgenic mice is associated with oxidative stress. 156
CSF and serum IgG and albumin in schizophrenics 156
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation 155
Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis 154
Aβ 1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation. 154
A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. 153
Position paper of the Italian Society for the study of Dementias (Sindem) on the proposal of a new Lexicon on Alzheimer disease. 153
The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment 153
Presence of soluble amyloid beta peptide precedes amyloid plaque formation in Down's syndrome 152
Neuronal apoptosis is accompanied by selective intracellular A-beta production and APP caspase cleavage 152
Beta-amyloid is different in normal aging and in Alzheimer's disease 152
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration 150
Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects 150
Relationship between Balance and Cognitive Performance in Older People 150
Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment 149
Creutzfeldt-Jakob disease in the city and district of Genoa: estimated mortality rate in the six year period 1974-1979. 149
A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene) 149
Amyloid-β Production: Major Link Between Oxidative Stress and BACE1. 149
Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. 147
Oxidative damage in the olfactory system in Alzheimer’s disease. 146
The 14-3-3 protein in multiple sclerosis: a marker of disease severity. 146
Early myoclonus and quasiperiodic EEG changes in non-familial Alzheimer's disease. 146
The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease 146
Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice 146
Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. 145
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome brains 145
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. 145
Opposite role of apolipoprotein E in normal brain and Alzheimer's disease 144
Generation of an apoptotic intracellular peptdide by g-secretase cleavage of Alzheimer’s amyliod b-protein precursor. 143
Amyloid beta protein deposition in brains from elderly subjects with leukoaraiosis. 141
Peripheral neuropathy in Cockayne syndrome. 141
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells 138
A simple, inexpensive, and precise spectrophotometric method for evaluating the concentration of ascorbic acid in CSF samples: data from different neurological pathologies. 138
The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons. 137
Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations. 136
Oxidative stress in Alzheimer disease: A possibility for prevention. 135
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism 135
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases. 135
Non traumatic dissecting aneurysm of the basilar artery 135
The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies 135
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. 134
Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation. 134
Microarray analysis in Alzheimer’s disease and normal aging 133
Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells 132
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. 132
Mitochondrial abnormalities in Alzheimer disease. 131
Oxidative stress and neuronal adaptation in Alzheimer disease : the role of SAPK pathways. 130
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 130
Plasma levels of amyloid beta 40 and 42 are independent from apoE genotype and mental retardation in Down syndrome 129
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 128
Italian multicenter study of dementia: a pathologically verified case of Alzheimer disease. 128
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (Progressive Supranuclear Palsy) 128
Skin fibroblasts in Huntington's disease. An electron microscopic study. 127
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. 126
Is amyloid beta-protein glycated in Alzheimer disease? 126
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. 126
Neurosyphilis presenting as a progressive supranuclear palsy 125
Polyglucosan bodies in the sural nerve of a diabetic patient with polyneuropathy. 125
Plasma levels of amyloid b-protein 42 are increased in women with mild cognitive impairment 125
Validity and reliability of the preliminary NINDS neuropathologic criteria for Progressive Supranuclear Palsy and related disorders 125
Totale 15.645
Categoria #
all - tutte 68.826
article - articoli 68.826
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.652


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.815 0 0 160 259 87 98 91 507 86 221 70 236
2022/20231.825 199 123 11 164 305 344 22 139 340 8 154 16
2023/2024769 37 133 7 88 75 89 41 80 43 8 53 115
2024/20252.442 52 202 67 159 341 263 209 370 108 127 240 304
2025/20264.388 540 107 265 450 573 506 773 185 255 378 177 179
2026/2027884 459 93 332 0 0 0 0 0 0 0 0 0
Totale 23.175